The Latest Cardiac and Vascular News
Patent Underscores AI for Vectorcardiography (VECG) IP Leadership Effort SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D vector electrocardiogram (VECG) platform intended for patient use at home, today announced […]
Patented Technology Provides Protection for HeartBeam AIMIGo™ Credit Card-sized Device in European Market SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, announced […]
Partnership Positions AIMIGo for Early Market Testing in Q2 2023 After Expected FDA Clearance December 07, 2022 08:31 AM Eastern Standard Time SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector […]
